| 0 (0%) | 12-26 22:18 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 857.51  |
1-year : | 899.33 |
| Resists | First : | 734.17 |
Second : | 769.97 |
| Pivot price | 698.7  |
|||
| Supports | First : | 676.23 |
Second : | 562.63 |
| MAs | MA(5) : | 692.28 |
MA(20) : | 706.93 |
| MA(100) : | 666.25 |
MA(250) : | 0 | |
| MACD | MACD : | -3.1 |
Signal : | 0.7 |
| %K %D | K(14,3) : | 19.1 |
D(3) : | 19.3 |
| RSI | RSI(14): 44 |
|||
| 52-week | High : | 769.97 | Low : | 356.14 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ IDXX ] has closed above bottom band by 18.0%. Bollinger Bands are 59.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 689.95 - 692.51 | 692.51 - 694.56 |
| Low: | 675.73 - 679 | 679 - 681.63 |
| Close: | 683.59 - 688.62 | 688.62 - 692.66 |
Wed, 24 Dec 2025
Vontobel Holding Ltd. Has $94.16 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Wed, 24 Dec 2025
Friedenthal Financial Buys New Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Tue, 23 Dec 2025
Westwind Capital Decreases Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Mon, 22 Dec 2025
Riverbridge Partners LLC Reduces Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Sun, 21 Dec 2025
3,727 Shares in IDEXX Laboratories, Inc. $IDXX Acquired by USA Financial Formulas - MarketBeat
Fri, 05 Dec 2025
At US$717, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 80 (M) |
| Shares Float | 79 (M) |
| Held by Insiders | 0.6 (%) |
| Held by Institutions | 95.3 (%) |
| Shares Short | 2,220 (K) |
| Shares Short P.Month | 1,720 (K) |
| EPS | 12.6 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 19.51 |
| Profit Margin | 24.6 % |
| Operating Margin | 32.1 % |
| Return on Assets (ttm) | 24 % |
| Return on Equity (ttm) | 64.6 % |
| Qtrly Rev. Growth | 13.3 % |
| Gross Profit (p.s.) | 32.18 |
| Sales Per Share | 52.22 |
| EBITDA (p.s.) | 18.03 |
| Qtrly Earnings Growth | 21.3 % |
| Operating Cash Flow | 1,090 (M) |
| Levered Free Cash Flow | 675 (M) |
| PE Ratio | 54.59 |
| PEG Ratio | 0 |
| Price to Book value | 35.28 |
| Price to Sales | 13.18 |
| Price to Cash Flow | 50.43 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|